Rchr
J-GLOBAL ID：200901093882227177   Update date: Nov. 12, 2024

Yoshimoto Takanobu

ヨシモト タカノブ | Yoshimoto Takanobu
Affiliation and department：
Institute of Science Tokyo University Hospital of Medicine, Clinics Department of Internal Medicine, Department of Clinical and Molecular Endocrinology

About Institute of Science Tokyo University Hospital of Medicine, Clinics Department of Internal Medicine, Department of Clinical and Molecular Endocrinology


Research field  (2)： Metabolism and endocrinology ,  Cardiology
Research keywords  (4)： 血管生物学 ,  高血圧 ,  Vascular Biology ,  Hypertension
Research theme for competitive and other funds  (12)：
  • 2019 - 2022 significance of micro RNA as biomarker in primary aldosteronism
  • 2016 - 2019 Genomics in primary aldosteronism
  • 2012 - 2015 Pathophysiology of aldosterone inducible genes
  • 2008 - 2010 Comprehensive analysis of aldosterone-regulated genes in human vascular cells
  • 2006 - 2007 Mechanism of aldosterone-induced vascular injury: role of angiotensin II and other factors
Show all
Papers (51)：
  • Aya Saiki, Michio Otsuki, Daisuke Tamada, Tetsuhiro Kitamura, Iichiro Shimomura, Isao Kurihara, Takamasa Ichijo, Yoshiyu Takeda, Takuyuki Katabami, Mika Tsuiki, et al. Diabetes Mellitus Itself Increases Cardio-Cerebrovascular Risk and Renal Complications in Primary Aldosteronism. The Journal of clinical endocrinology and metabolism. 2020. 105. 7
  • Youichi Ohno, Masakatsu Sone, Nobuya Inagaki, Akiyuki Kawashima, Yoshiyu Takeda, Takashi Yoneda, Isao Kurihara, Hiroshi Itoh, Mika Tsuiki, Takamasa Ichijo, et al. Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism. Hypertension (Dallas, Tex. : 1979). 2020. 75. 6. 1475-1482
  • Ryo Nakamaru, Koichi Yamamoto, Hiromi Rakugi, Hiroshi Akasaka, Isao Kurihara, Takamasa Ichijo, Yoshiyu Takeda, Takuyuki Katabami, Mika Tsuiki, Norio Wada, et al. Obesity predicts persistence of resistant hypertension after surgery in patients with primary aldosteronism. Clinical endocrinology. 2020. 93. 3. 229-237
  • Aya Saiki, Michio Otsuki, Kosuke Mukai, Reiko Hayashi, Iichiro Shimomura, Isao Kurihara, Takamasa Ichijo, Yoshiyu Takeda, Takuyuki Katabami, Mika Tsuiki, et al. Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism. Journal of the Endocrine Society. 2020. 4. 4. bvaa011
  • Hiroki Kobayashi, Masanori Abe, Yoshihiro Nakamura, Katsutoshi Takahashi, Megumi Fujita, Yoshiyu Takeda, Takashi Yoneda, Isao Kurihara, Hiroshi Itoh, Mika Tsuiki, et al. Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function. Hypertension (Dallas, Tex. : 1979). 2019. 74. 3. 630-638
ｍore...
MISC (35)：
  • Kiichiro Hiraishi, Takanobu Yoshimoto, Kyoichiro Tsuchiya, Hajime Izumiyama, Masaru Doi, Hironobu Sasano, Yukio Hirata. Primary aldosteronism is frequently associated with subclinical Cushing's syndrome. ENDOCRINE JOURNAL. 2010. 57. S634-S635
  • Eri Hayakawa, Takanobu Yoshimoto, Naoko Sekizawa, Kyoichiro Tsuchiya, Toru Sugiyama, Yukio Hirata. Enhanced expression of monocyte chemoattractant protein(MCP)-1 in vascular smooth muscle cells with overexpressed receptor for advanced glycation end products(RAGE). ENDOCRINE JOURNAL. 2010. 57. S573-S573
  • Yoshio Terada, Hitoshi Kuwana, Takahiko Kobayashi, Tomokazu Okado, Noriko Suzuki, Takanobu Yoshimoto, Yukio Hirata, Sei Sasaki. Aldosterone-stimulated SGK1 activity mediates profibrotic signaling in the mesangium. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2008. 19. 2. 298-309
  • Kyoichiro Tsuchiya, Haruna Sakai, Noriko Suzuki, Fumiko Iwashima, Takanobu Yoshimoto, Masayoshi Shichiri, Yukio Hirata. Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice. ENDOCRINOLOGY. 2007. 148. 10. 4548-4556
  • Takanobu Yoshimoto, Yukio Hirata. Bosentan for treatment of heart failure. Nippon rinsho. Japanese journal of clinical medicine. 2007. 65. 159-163
ｍore...
Works (4)：
  • インスリン抵抗性改善による血管保護作用
    1998 - 1999
  • Vasculo protective effect through insulin sensitizing
    1998 - 1999
  • インスリン抵抗性改善と腎保護作用
    1996 - 1997
  • Renoprotective effects through insulin sensitizing
    1996 - 1997
Education (4)：
  • - 1996 Tokyo Women's Medical University
  • - 1996 Tokyo Women's Medical University Graduate School, Division of Medicine Internal Medicine(Endocrinology)
  • - 1990 Tohoku University Faculty of Medicine
  • - 1990 Tohoku University Faculty of Medicine
Professional career (1)：
  • Doctor(Medicine) (Tokyo Women's Medical University)
Work history (9)：
  • 1999 - 2002 米国国立衛生研究所(NIH) 研究員
  • 1999 - 2002 Research Fellow,
  • 2002 - - 東京医科歯科大学 助手
  • 2002 - - Assistant Professor,
  • 1997 - 1999 Tokyo Women's Medical University
Show all
Committee career (2)：
  • 1996 - 2002 日本心血管内分泌代謝学会 評議員
  • 1996 - 2002 Japanese Society of Cardiovascular Endocrinology and Metabolism Diplomat
Awards (4)：
  • 1997 - 東京高血圧研究会 研究助成
  • 1997 - 日本高血圧学会 Young Investigator Award
  • 1997 - Research Promotion Award from Tokyo Hypertension Conference
  • 1997 - Young Investigator Award from Japanese Society of Hypertension
Association Membership(s) (7)：
日本高血圧学会 ,  日本内分泌学会 ,  日本心血管内分泌代謝学会 ,  Japanese Society of Hypertension ,  Japan Endocrine Sosiety ,  and Metabolism ,  Japanese Society of Cardiovascular Endocrinology
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM